A number of molecules, such as miR-29a [18,19], DKK1 [20] and osteopontin [21], have been shown to have effective clinical significance for predicting HCC prognosis, but the prognosis for HCC remains poor. This evidence concerns the gene SPP1 and hepatocellular carcinoma.